Financial Performance

As Maze Therapeutics prepares for a transatlantic investor conference circuit, the biotech leverages a $495M war chest ahead of a catalyst-rich 2027.

Following Alcon’s acquisition of LumiThera, spin-out OpZira targets the New York Venture Summit to capitalize on the booming ophthalmic diagnostic market.

Lakefront Biotherapeutics appoints Dr. Mehdi Shahidi, blending oncology expertise with capital discipline to accelerate its autoimmune T-cell engager pipeline.

Brian Nelson unpacks FIT KING's sponsorship of the San Diego Triathlon Challenge, revealing the hidden economics and tech driving adaptive sports.

As the AI infrastructure rush strains global supply chains, Digital Realty is deploying automated schedule analytics to keep its $22 billion pipeline on track.

By blending equity and convertible debt, Rapport Therapeutics just secured a massive $410 million war chest, extending its clinical runway through 2029.

Canadian defined benefit plans posted negative returns in Q3, but surging bond yields mask a hidden victory for long-term pension solvency.

As hyperscalers dominate the headlines, a new $106 million debt facility reveals how private credit is transforming GPU clusters into a structured asset class.

As Aptiv prepares for Electronica 2026, its aggressive expansion into AI data centers, robotics, and aerospace reveals a masterclass in diversification.

As Opportunity Zones become a permanent fixture in the tax code, a $100 billion wave of capital forces a reckoning on gentrification and rural revitalization.

Carry The Load and G.E.H.A are transforming Veterans Day from a passive holiday into a monthlong, data-driven physical intervention for mental health.

A new shared satellite model allows nations to deploy 5G direct-to-device networks without surrendering data control to proprietary mega-constellations.

As high interest rates squeeze developers, Venu Holding Corporation pivots to strategic partnerships and municipal backing to fund its luxury live music expansion.

As generative AI transforms product discovery, retailers are abandoning traditional storefronts to battle over the invisible infrastructure of data feeds.

A new land-based sediment basin resolves a bitter dispute between ferry operators and local fishers, but a harsh winter construction deadline looms.

As Upstate New York pivots from legacy manufacturing to quantum computing and deep tech, the 2026 Innovation Summit offers a blueprint for reindustrialization.

As traditional reinsurance faces capacity crunches, Cayman-based Re is leveraging stablecoins and legacy talent to build a fully collateralized market.

As ORIC Pharmaceuticals prepares to unveil pivotal clinical data in Madrid, the focus shifts to brain-penetrant lung cancer therapies and epigenetic modulation.

As antimicrobial resistance threatens global health, Paratek Pharmaceuticals leverages a $304 million BARDA contract to expand NUZYRA's clinical footprint.

Trial lawyer Troy Rafferty helped secure $20M for reform school survivors. Now, he's highlighting the critical need for civil legal aid in Northwest Florida.